The study by De Luca et al.
A Word of Caution
The study by De Luca et al. (1) elegantly demonstrates that increasing doses of intracoronary adenosine are associated with incremental reductions in fractional flow reserve. We would like to caution, however, against high-dose intracoronary adenosine administration in the right coronary artery. Although none of the 12 patients who underwent right coronary artery evaluation in the present study had a clinical event, 3 of them developed complete atrioventricular block lasting Ͼ4 s. Prolonged complete atrioventricular block can lead to ventricular fibrillation or atrial fibrillation (2) , both important complications that may require emergent defibrillation. Hence, intravenous administration may be the preferred route for vasodilator administration for fractional flow reserve measurement in the right coronary artery. 
*Emmanouil S. Brilakis, MD, PhD

Reply
We would like to thank Drs. Brilakis and Banerjee for their interest in our study (1) . In our extensive experience (1,2), we have never had any relevant complications, especially atrial or ventricular fibrillation, with adenosine administration in the right coronary artery. This is consistent with data shown by other authors (3). As stated in our paper (1), we had to stop the protocol in 4 patients due to atrioventricular block that technically hampered the evaluation of fractional flow reserve. Therefore, we believe that it is not worthwhile to increase the dose of adenosine in the evaluation of fractional flow reserve when there is already a relevant atrioventricular block with a low dose. 
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